Physician profile
Caroline Michael
NPI 1538753116
$965.78
in general payments reported to CMS, 2019-2025
18 companies · $60.44 in 2025
The $60.44 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $576 · 2022: $175 · 2023: $40.43 · 2024: $114 · 2025: $60.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $214.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $177.09 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $164.03 | 2021 | |
| Abbvie INC. | $84.77 | 2021-2024 | |
| Lilly USA, LLC | $83.38 | 2021-2023 | Mounjaro |
| Glaxosmithkline, LLC. | $53.93 | 2021-2024 | Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.72 | 2021-2022 | |
| Amarin Pharma, INC. | $48.32 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $46.60 | 2021-2024 | |
| Novo Nordisk INC | $40.20 | 2021-2022 | |
| Pfizer INC. | $37.02 | 2024-2025 | |
| Eyevance Pharmaceuticals LLC | $31.29 | 2021 | |
| Hikma Pharmaceuticals USA | $31.29 | 2021 | |
| Astellas Pharma US INC | $29.59 | 2025 | Veozah |
| Idorsia Pharmaceuticals US INC | $25.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.44 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.90 | 2021 | |
| Exact Sciences Corporation | $14.39 | 2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Michael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.